Advanced search
Publication Cover
Cancer Management and Research Volume 9, 2017 - Issue
Submit an article Journal homepage
126
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells

Hailun Zheng1 Department of Coloproctology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University;2 Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China
,
Huang Hong1 Department of Coloproctology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University
,
Lulu Zhang1 Department of Coloproctology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University;2 Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China
,
Xiong Cai1 Department of Coloproctology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University;2 Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China
,
Meng Hu1 Department of Coloproctology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University;2 Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China
,
Yuepiao Cai2 Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China
,
Bin Zhou1 Department of Coloproctology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University
,
Jiayuh Lin3 Department of Biochemistry and Molecular Biology, University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MA, USA
,
Chengguang Zhao2 Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of ChinaCorrespondence[email protected]
&
Wanle Hu1 Department of Coloproctology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical UniversityCorrespondence[email protected]
 show all
Pages 565-572 | Published online: 01 Nov 2017

References

  • ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
  • SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
  • SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
  • ShitaraKKadowakiSNishinaTSafety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naive metastatic gastric/gastroesophageal junction cancerGastric Cancer Epub2017630
  • KoderaYFujitaniKFukushimaNSurgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelinesGastric Cancer201417220621224022130
  • Thuss-PatiencePCShahMAOhtsuATrastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 studyLancet Oncol201718564065328343975
  • YuHPardollDJoveRSTATs in cancer inflammation and immunity: a leading role for STAT3Nat Rev Cancer200991179880919851315
  • YuHLeeHHerrmannABuettnerRJoveRRevisiting STAT3 signalling in cancer: new and unexpected biological functionsNat Rev Cancer2014141173674625342631
  • ZhaoCLiHLinHJYangSLinJLiangGFeedback activation of STAT3 as a cancer drug-resistance mechanismTrends Pharmacol Sci2016371476126576830
  • HuynhJEtemadiNHollandeFErnstMBuchertMThe JAK/STAT3 axis: a comprehensive drug target for solid malignanciesSemin Cancer Biol201745132228647610
  • LinLHutzenBZuoMNovel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cellsCancer Res20107062445245420215512
  • RathKSNaiduSKLataPHO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancerCancer Res20147482316232724590057
  • HubbardJMGrotheyANapabucasin: an update on the first-in-class cancer stemness inhibitorDrugs201777101091110328573435
  • JonkerDJNottLYoshinoTA randomized phase III study of napabucasin [BBI608] (NAPA) vs placebo (PBO) in patients (pts) with pretreated advanced colorectal cancer (ACRC): the CCTG/AGITG CO.23 trialAnn Oncol2016276149206
  • GrotheyATebbuttNVan CutsemECanStem303C trial: a phase III study of BBI-608 (napabucasin) in combination with 5-fluorouracil (5-FU), leucovorin, irinotecan (FOLFIRI) in adult patients with previously treated metastatic colorectal cancer (mCRC)Ann Oncol2016276149206
  • PolattiFBacterial vaginosis, Atopobium vaginae and nifuratelCurr Clin Pharmacol201271364022082330
  • BrumfittWReynoldsAVHamilton-MillerJMLetter: activity of nitrofurantoin and nifuratel against anaerobic Gram-negative bacilliLancet197517904460
  • YeTHYangFFZhuYXInhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasisCell Death Dis201781e253428055016
  • NelsonEAWalkerSRKepichANifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3Blood2008112135095510218824601
  • JangWKimTKooJSKimSKLimDSMechanical cue-induced YAP instructs Skp2-dependent cell cycle exit and oncogenic signalingEMBO J201736172510252828673931
  • WangTTZhaoYLPengLSTumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathwayGut Epub201738
  • HowlettMMenheniottTRJuddLMGiraudASCytokine signalling via gp130 in gastric cancerBiochim Biophys Acta20091793111623163319665497
  • LongKBTookerGTookerEIL-6 receptor blockade enhances chemotherapy efficacy in pancreatic ductal adenocarcinomaMol Cancer Ther20171691898190828611107
  • BhartiRDeyGBanerjeeISomatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapyCancer Lett201738829230228025102
  • BhartiRDeyGOjhaPKDiacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancerOncogene201635303965397526616855
  • MedlockJDasAAKMaddenLAAllsupDJPaunovVNCancer bioimprinting and cell shape recognition for diagnosis and targeted treatmentChem Soc Rev201746165110512728660268
  • MillerMAWeisslederRImaging of anticancer drug action in single cellsNat Rev Cancer201717739941428642603
  • JungKHYooWStevensonHLMulti-functional effects of a small-molecule STAT3 inhibitor on NASH and HCC in miceClin Cancer Res201723185537554628533225

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.